MedTech/CERENOVUS is removing CEREPAK Detachable Coil Systems due to a higher than expected failure to detach rate
Similar Posts
Patent Certifications and Suitability Petitions
Information on patents and suitability petitions that impact the availability of generic drugs.Generic Drugs Program Monthly and Quarterly Activities Report
Monthly and quarterly metrics of the FDA Generic Drugs Program.Guangxi Yulin Pharmaceutical Group Co. Ltd. – 710422 – 09/30/2025
CGMP/Finished Pharmaceuticals/AdulteratedInnovative Science and Technology Approaches for New Drugs (ISTAND) Program
The Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program is designed to expand DDT types by encouraging development of DDTs that are out of scope for existing DDT qualification programs but may still be beneficial for drug development.Revance Therapeutics – 7/15/2022
Revance Therapeutics – 7/15/2022. Country: USA. Record Type: 483Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Drug Shortage Mitigation Efforts
The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law on March 27, 2020 to aid response efforts and ease the economic impact of COVID-19.